Z. Ilyas, S. Perna, T. A Alalwan, MN. Zahid, D. Spadaccini, C. Gasparri, G. Peroni, A. Faragli, A. Alogna, E. La Porta, A. Ali Redha, M. Negro, G. Cerullo, G. D'Antona, et al. (2022). The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity?. Nutrients, 14(3). https://doi.org/10.3390/nu14030620

PubMed 35276979

[Abstract]
This review aims to define the effectiveness of the ketogenic diet (KD) for the management of sarcopenic obesity. As the combination of sarcopenia and obesity appears to have multiple negative metabolic effects, this narrative review discusses the effects of the ketogenic diet as a possible synergic intervention to decrease visceral adipose tissue (VAT) and fatty infiltration of the liver as well as modulate and improve the gut microbiota, inflammation and body composition. The results of this review support the evidence that the KD improves metabolic health and expands adipose tissue γδ T cells that are important for glycaemia control during obesity. The KD is also a therapeutic option for individuals with sarcopenic obesity due to its positive effect on VAT, adipose tissue, cytokines such as blood biochemistry, gut microbiota, and body composition. However, the long-term effect of a KD on these outcomes requires further investigations before general recommendations can be made.